PRIORIX-TETRA 1000 CCID50 / 0.5 ML
RUBELLA VIRUS VACCINE LIVE ATTENUATED (WISTAR RA27/3 STRAIN) : 1000 CCID50 / 0.5 ML VARICELLA-ZOSTER VIRUS VACCINE LIVE ATTENUATED (OKA-STRAIN) : 1995.2623 CCID50 / 0.5 ML MUMPS VIRUS VACCINE LIVE ATTENUATED (JERYL LYNN STRAIN) : 25118.9 CCID50 / 0.5 ML MEASLES VIRUS VACCINE LIVE ATTENUATED : 1000 CCID50 / 0.5 ML · DIN 02297884 · GLAXOSMITHKLINE INC
Health Canada status: MARKETED
What is PRIORIX-TETRA?
PRIORIX-TETRA 1000 CCID50 / 0.5 ML contains RUBELLA VIRUS VACCINE LIVE ATTENUATED (WISTAR RA27/3 STRAIN) : 1000 CCID50 / 0.5 ML VARICELLA-ZOSTER VIRUS VACCINE LIVE ATTENUATED (OKA-STRAIN) : 1995.2623 CCID50 / 0.5 ML MUMPS VIRUS VACCINE LIVE ATTENUATED (JERYL LYNN STRAIN) : 25118.9 CCID50 / 0.5 ML MEASLES VIRUS VACCINE LIVE ATTENUATED : 1000 CCID50 / 0.5 ML. It is listed in the Health Canada Drug Product Database under DIN 02297884, held by GLAXOSMITHKLINE INC, supplied as POWDER FOR SOLUTION for INTRAMUSCULAR ; SUBCUTANEOUS administration. Health Canada currently lists it as marketed, status dated 02-Mar-2026. Nexara Health is a licensed Canadian wholesale distributor (DEL 3-002896-A) and can source this product for hospitals, pharmacies and clinics. Availability and lead time are confirmed per order.
What is PRIORIX-TETRA used for?
PRIORIX-TETRA (combined measles, mumps, rubella and varicella vaccine, live, attenuated) is indicated for active immunization against measles, mumps, rubella and varicella in individuals from 9 months to 6 years of age. Efficacy has not been evaluated in subjects above 6 years of age. PRIORIX-TETRA may be used in individuals up to 12 years of age based upon previous experience with the separate component vaccines, PRIORIX (combined measles, mumps and rubella vaccine, live, attenuated) and VARILRIX [varicella virus vaccine, live, attenuated (OKA - strain)].
Authorized indication as written in the Health Canada product monograph. For healthcare professionals and licensed purchasers; this is not medical advice.
Product details and regulatory record
| DIN | 02297884 |
|---|---|
| Brand name | PRIORIX-TETRA |
| Generic / active ingredient | RUBELLA VIRUS VACCINE LIVE ATTENUATED (WISTAR RA27/3 STRAIN) : 1000 CCID50 / 0.5 ML VARICELLA-ZOSTER VIRUS VACCINE LIVE ATTENUATED (OKA-STRAIN) : 1995.2623 CCID50 / 0.5 ML MUMPS VIRUS VACCINE LIVE ATTENUATED (JERYL LYNN STRAIN) : 25118.9 CCID50 / 0.5 ML MEASLES VIRUS VACCINE LIVE ATTENUATED : 1000 CCID50 / 0.5 ML |
| Manufacturer | GLAXOSMITHKLINE INC |
| Strength | 1000 CCID50 / 0.5 ML |
| Dosage form | POWDER FOR SOLUTION |
| Route of administration | INTRAMUSCULAR ; SUBCUTANEOUS |
| Schedule | Schedule D |
| ATC code | J07BD54 MEASLES, COMBINATIONS WITH MUMPS, RUBELLA AND VARICELLA, LIVE ATTENUATED |
| Biosimilar | No |
| Health Canada status | MARKETED |
| Status date | 02-Mar-2026 |
How is it stored and handled?
Store PRIORIX-TETRA (combined measles, mumps, rubella and varicella vaccine, live, attenuated) at 2 to 8°C (in a refrigerator). Do not freeze. Store in the original packaging in order to protect from light. The reconstituted vaccine should be administered as soon as possible. It may be kept up to 8 hours in the refrigerator (2 to 8°C).
How is it supplied?
1, 10, or 100 mono dose vials
What can be used instead?
Other Canadian products sharing ATC code J07BD54 MEASLES, COMBINATIONS WITH MUMPS, RUBELLA AND VARICELLA, LIVE ATTENUATED. 2 of 2 DINs in this group are currently marketed — marketed products are listed first, because that is what can actually be bought. These tables describe supply, not clinical equivalence: substitution rests with the prescriber or pharmacist, and interchangeability is determined provincially.
| Product | Strength | Form | Manufacturer | Health Canada status | DIN |
|---|---|---|---|---|---|
| PROQUAD | 3.99 Log10 PFU / 0.5 ML | POWDER FOR SOLUTION | MERCK CANADA INC | MARKETED | DIN 02399229 |
How can I get it?
Nexara Health supplies this product to licensed Canadian buyers — pharmacies, hospitals, clinics, licensed distributors, and clinical trial sponsors or their CROs. We confirm stock, pack size, expiry and pricing at the time of quotation. If the product is on backorder or in shortage, we identify equivalent alternatives and import options where permitted.
Ordering questions
Who can buy this from Nexara?
Licensed entities only. Nexara holds Health Canada establishment licence DEL 3-002896-A and ships only to a licensed address.
Is there a minimum order?
Yes, set per product line and per pack multiple rather than on the order total, so you are never asked to buy a part-pack. The minimum for this line is confirmed with your quote.
What is the lead time?
Confirmed per order at quotation, and it depends on current stock position and whether the product is in shortage.
Can Nexara supply this for a clinical trial?
Yes — comparator and background-therapy supply, including sourcing from other markets where a Canadian pack will not satisfy the protocol. Clinical trial supply.